SCHEMBL7154751

SCHEMBL7154751

O=C1C(O)=C(O)C(=O)c2c1ccc(O)c2O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.69
▸ MEN1 O00255 7/20 0.69
▸ KMT2A Q03164 7/20 0.69
▸ MAOA P21397 6/20 0.69
▸ ALDH1A1 P00352 6/20 0.69
▸ MAPK1 P28482 5/20 0.69
▸ HPGD P15428 5/20 0.69
▸ KDM4E B2RXH2 4/20 0.69
▸ RECQL P46063 4/20 0.69
▸ ALOX15 P16050 4/20 0.69
▸ HSD17B10 Q99714 4/20 0.69
▸ TDP1 Q9NUW8 4/20 0.69
▸ CYP3A4 P08684 3/20 0.69
▸ APEX1 P27695 2/20 0.69
▸ THRB P10828 2/20 0.69
▸ BRCA1 P38398 2/20 0.69
▸ USP2 O75604 1/20 0.69
▸ RAF1 P04049 1/20 0.69
▸ TP53 P04637 1/20 0.69
▸ CSNK2A2 P19784 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2772226 0.88 MAPT (0.86) MAPTMEN1KMT2AMAOAALDH1A1
SCHEMBL6904748 0.86 MAPT (0.83) MAPTMEN1KMT2AMAOAALDH1A1
Dioncoquinone B SCHEMBL3401149 0.84 MEN1 (0.60) MAPTMEN1KMT2AMAOAALDH1A1
Quinalizarin SCHEMBL138122 0.82 MAOA (1.00) MAPTMEN1KMT2AMAOAALDH1A1
Quinalizarin SCHEMBL29516323 0.82 MAOA (1.00) MAPTMEN1KMT2AMAOAALDH1A1
Quinalizarin SCHEMBL20608650 0.82 MAOA (1.00) MAPTMEN1KMT2AMAOAALDH1A1
Quinalizarin SCHEMBL29437816 0.82 MAOA (1.00) MAPTMEN1KMT2AMAOAALDH1A1
SCHEMBL11055115 0.80 MAPT (0.80) MAPTMEN1KMT2AMAOAALDH1A1
Athraquinones A SCHEMBL18614 0.78 MAPT (1.00) MAPTMEN1KMT2AMAOAALDH1A1
Athraquinones A SCHEMBL21114402 0.78 MAPT (1.00) MAPTMEN1KMT2AMAOAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0868756-A4 ELECTROCHEMICAL CELL WITH A NON-LIQUID ELECTROLYTE E C R ELECTRO CHEMICAL RES LTD (IL) 2003-09-10 — — EP claimed
US-20020122980-A1 Can be used as power sources for storage and release of electrical energy such as batteries, capacitors and hybrid electrochemical cells termed batcaps FLEISCHER NILES A (IL) 2002-09-05 — — US claimed
JP-2002507310-A — — 2002-03-05 — — JP claimed
US-6225009-B1 Electrochemical cell with a non-liquid electrolyte E.C.R. -ELECTRO-CHEMICAL RESEARCH LTD. (IL) 2001-05-01 — — US claimed
EP-0868756-A1 ELECTROCHEMICAL CELL WITH A NON-LIQUID ELECTROLYTE E.C.R. - ELECTRO-CHEMICAL RESEARCH LTD. (IL) 1998-10-07 — — EP claimed
WO-1998013887-A1 ELECTROCHEMICAL CELL WITH A NON-LIQUID ELECTROLYTE E.C.R. - ELECTRO-CHEMICAL RESEARCH LTD. (IL) 1998-04-02 — — WO claimed
US-5731105-A Battery electrochemical cell with a non-liquid electrolyte E.C.R. - ELECTRO-CHEMICAL RESEARCH LTD. (IL) 1998-03-24 — — US claimed
US-5580681-A SOLID ELECTROLYTE, ORGANIC ANODE, SOLID CATHODE E.C.R.-ELECTRO-CHEMICAL RESEARCH LTD. (IL) 1996-12-03 — — US claimed
US-20250295121-A1 COMPOSITIONS, SYSTEMS, AND METHODS FOR INCREASED PLANT QUALITY RDX-N, LLC 2025-09-25 — — US disclosed
EP-4601469-A1 COMPOSITIONS, SYSTEMS, AND METHODS FOR INCREASED PLANT QUALITY RDX-N, LLC (US) 2025-08-20 — — EP disclosed
US-12349681-B2 Compositions, systems, and methods for increased plant quality RDX-N, LLC (US) 2025-07-08 — — US disclosed
US-12027314-B2 Flexible energy storage device based on gylcerol gel electrolyte IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2024-07-02 — — US disclosed
EP-3280402-B1 TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING BIOMENDICS LLC (US) 2024-06-05 — — EP disclosed
US-20240122187-A1 COMPOSITIONS, SYSTEMS, AND METHODS FOR INCREASED PLANT QUALITY RDX-N, LLC 2024-04-18 — — US disclosed
US-20160296477-A1 Formulation and Process for Modulating Wound Healing BioMendics, LLC (US) 2016-10-13 — — US disclosed
CN-101137663-A Novel aromatic prenyltransferases, nucleic acids encoding same and uses thereof SALK INST FOR BIOLOGICAL STUDI (US) 2008-03-05 — — CN disclosed
US-20020122980-A1 Can be used as power sources for storage and release of electrical energy such as batteries, capacitors and hybrid electrochemical cells termed batcaps FLEISCHER NILES A (IL) 2002-09-05 — — US disclosed
US-6225009-B1 Electrochemical cell with a non-liquid electrolyte E.C.R. -ELECTRO-CHEMICAL RESEARCH LTD. (IL) 2001-05-01 — — US disclosed
US-5731105-A Battery electrochemical cell with a non-liquid electrolyte E.C.R. - ELECTRO-CHEMICAL RESEARCH LTD. (IL) 1998-03-24 — — US disclosed
US-5580681-A SOLID ELECTROLYTE, ORGANIC ANODE, SOLID CATHODE E.C.R.-ELECTRO-CHEMICAL RESEARCH LTD. (IL) 1996-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160296477-A1 Formulation and Process for Modulating Wound Healing SQSTM1, ATG7, TFEB MAPT 3766/4885MEN1 4604/4885KMT2A 3474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback